ALBO - Albireo Pharma GAAP EPS of -$0.57 revenue of $32.52M
Albireo Pharma press release (NASDAQ:ALBO): Q4 GAAP EPS of -$0.57. Revenue of $32.52M (vs $2.72M in Q420).
For further details see:
Albireo Pharma GAAP EPS of -$0.57, revenue of $32.52MLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Albireo Pharma Inc. |
| Stock Symbol: | ALBO |
| Market: | NASDAQ |
Get ALBO Alerts
News, Short Squeeze, Breakout and More Instantly...